Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib

Por Kirane, Amanda, Toombs, Jason E, Larsen, Jill E, Ostapoff, Katherine T, Meshaw, Kathryn R, Zaknoen, Sara, Brekken, Rolf A, Burrows, Francis J
Publicado em 2012

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

Por Paterson, Ross W., Slattery, Catherine F., Poole, Teresa, Nicholas, Jennifer M., Magdalinou, Nadia K., Toombs, Jamie, Chapman, Miles D., Lunn, Michael P., Heslegrave, Amanda J., Foiani, Martha S, Weston, Philip S. J., Keshavan, Ashvini, Rohrer, Jonathan D., Rossor, Martin N., Warren, Jason D., Mummery, Catherine J., Blennow, Kaj, Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Publicado no Alzheimers Res Ther (2018)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes

Por Weston, Philip S.J., Paterson, Ross W., Modat, Marc, Burgos, Ninon, Cardoso, Manuel J., Magdalinou, Nadia, Lehmann, Manja, Dickson, John C., Barnes, Anna, Bomanji, Jamshed B., Kayani, Irfan, Cash, David M., Ourselin, Sebastien, Toombs, Jamie, Lunn, Michael P., Mummery, Catherine J., Warren, Jason D., Rossor, Martin N., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Publicado no Alzheimers Dement (Amst) (2015)